Zobrazeno 1 - 10
of 128
pro vyhledávání: '"V O, Speights"'
Autor:
Youngberg GA, Walker SW
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 1993 May; Vol. 6 (3), pp. 392-3.
Autor:
Martin L. Brady, King Scott Coffield, Thomas J. Kuehl, Raghu Raghavan, V. O. Speights, Belur Patel, Scott Wilson, Mike Wilson, Rick M. Odland
Publikováno v:
BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background New biologic therapies directly injected into the prostate are in clinical trials for prostatic diseases. There is a need to understand distribution of injected therapies as a function of prostatic anatomy, physiology, and device
Externí odkaz:
https://doaj.org/article/f373afd62b7047d7b806aab2ec7be85e
Publikováno v:
American journal of clinical pathology. 155(5)
Objectives We evaluated how the changes in Gleason grading affected the long-term outcomes of a large prostatectomy cohort. Methods We obtained long-term follow-up (16.7 years) in 581 patients having undergone radical retropubic prostatectomy between
Publikováno v:
World Journal of Oncology
Background: Historically, ploidy and S phase percentage appeared to be promising predictors for prostate cancer recurrence. Lack of uniformity and consistency hampered their development. We evaluated ploidy and S phase for prostate cancer death in a
Autor:
V. O. Speights, Michael T. Wilson, Thomas J. Kuehl, Martin Brady, K.S. Coffield, Rick M. Odland, Scott R. Wilson, Raghu Raghavan, Belur Patel
Publikováno v:
BMC Urology
BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
Background New biologic therapies directly injected into the prostate are in clinical trials for prostatic diseases. There is a need to understand distribution of injected therapies as a function of prostatic anatomy, physiology, and device design. M
Autor:
Debra G.B. Leonard, V. O. Speights, Richard L. Haspel, Frederic G. Barr, James B. Atkinson, Karen L. Kaul, Joan Scott, Henry M. Rinder, Julianne M. O’Daniel, Mark E. Sobel
Publikováno v:
Personalized Medicine. 9:287-293
Genomic technologies are dramatically changing the practice of medicine. Next-generation sequencing has allowed prognostic stratification of cancer patients, personalized drug therapy and the identification of genetic risk factors for a multitude of
Autor:
Jorja D Warren, Adib Younus, V. O. Speights, Jerry S. Lanchbury, Darl D. Flake, Henrik Møller, Arthur R. Brothman, Daniel M. Berney, Jack Cuzick, Susanne Wagner, Gabrielle Fisher, Gregory P. Swanson, Steven Stone, Jimmy Park, David Mesher, Alexander Gutin, Julia Reid, Christopher S. Foster, Elzbieta Stankiewicz, Peter T. Scardino
Publikováno v:
The Lancet Oncology. 12:245-255
Summary Background Optimum management of clinically localised prostate cancer presents unique challenges because of the highly variable and often indolent natural history of the disease. To predict disease aggressiveness, clinicians combine clinical
Autor:
Ronald B. Natale, Bryan Goldman, H. Barton Grossman, David P. Wood, Guru Sonpavde, Seth P. Lerner, Donald L. Trump, E. David Crawford, V. O. Speights, Nicholas J. Vogelzang
Publikováno v:
Cancer. 115:4104-4109
BACKGROUND: In a retrospective study of Southwestern Oncology Group (SWOG)-S8710/INT-0080 (radical cystectomy [RC] alone vs 3 cycles of neoadjuvant chemotherapy [NC] with methotrexate, vinblastine, doxorubicin, and cisplatin before RC for bladder can
Autor:
Darlene M, Miltenburg, V O, Speights
Publikováno v:
Obstetrics and Gynecology Clinics of North America. 35:285-300
Benign breast disease includes all nonmalignant conditions of the breast, including benign tumors, trauma, mastalgia, mastitis, and nipple discharge. Benign tumors include pathologic changes that do not increase a patient's risk for developing cancer
Publikováno v:
Endocrinology. 149:1180-1189
Endometriosis is a debilitating disease characterized by the presence of functional endometrial glandular epithelium and stroma outside the uterine cavity that affects up to 20% of women of child-bearing age. Cyclooxygenase-2 (COX-2), a rate-limiting